U.S. Markets closed

STADA Arzneimittel Aktiengesellschaft (SAZ.DE)

XETRA - XETRA Delayed Price. Currency in EUR
Add to watchlist
81.15+0.53 (+0.66%)
At close: 5:35PM CEST

STADA Arzneimittel Aktiengesellschaft

Stadastrasse 2-18
Bad Vilbel 61118
Germany
49 6101 603 0
http://www.stada.de

SectorHealthcare
IndustryDrugs - Generic
Full Time Employees11,013

Key Executives

NameTitlePayExercisedAge
Dr. Engelbert Coster Tjeenk Willink M.D.Chairman of Exec. Board & CEON/AN/A56
Dr. Bernhard DuettmannCFO & Member of Exec. BoardN/AN/A57
Dr. Barthold PieningChief Technical Operations Officer & Member of Exec. BoardN/AN/A59
Ms. Leslie Isabelle IltgenVP of Investor RelationsN/AN/AN/A
Mr. Sebastian Kramer-BachExec. VP of Corp. CommunicationN/AN/A42
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

STADA Arzneimittel Aktiengesellschaft engages in the development and marketing of active pharmaceutical ingredients for the health care and pharmaceutical markets worldwide. It operates through two segments, Generics and Branded Products. The Generics segment provides various generic active ingredients, including Tilidine naloxone for pain; Atorvastatin for elevated cholesterol levels; Pantoprazole for stomach ulcer/reflux; Diclofenac for pain/inflammation; and Enalapril for high blood pressure indications. The Branded Products segment offers APO-Go a Parkinson’s medicine; Aqualor for rhinitis/sore throat; Grippostad a cold medicine; Snup for rhinitis; and Vitaprost for prostate disease indications, as well as Ladival a sun protection product. The company is also involved in the wholesale activities in the pharmaceutical market. It serves patients and consumers, doctors, pharmacies and pharmacy chains, hospitals, mail-order companies, buying groups, wholesalers, and other service providers in the health care market, as well as public or private health insurance organizations. STADA Arzneimittel Aktiengesellschaft was founded in 1895 and is headquartered in Bad Vilbel, Germany.

Corporate Governance

STADA Arzneimittel Aktiengesellschaft’s ISS Governance QualityScore as of September 1, 2017 is 1. The pillar scores are Audit: 1; Board: 1; Shareholder Rights: 1; Compensation: 2.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.